| Literature DB >> 28051098 |
Junyoung Kim1, Hyung-Min Seo1, Shashi Kant Bhatia2, Hun-Seok Song1, Jung-Ho Kim1, Jong-Min Jeon1, Kwon-Young Choi3, Wooseong Kim4, Jeong-Jun Yoon5, Yun-Gon Kim6, Yung-Hun Yang1.
Abstract
Itaconate, a C5 unsaturated dicarboxylic acid, is an important chemical building block that is used in manufacturing high-value products, such as latex and superabsorbent polymers. Itaconate is produced by fermentation of sugars by the filamentous fungus Aspergillus terreus. However, fermentation by A. terreus involves a long fermentation period and the formation of various byproducts, resulting in high production costs. E. coli has been developed as an alternative for producing itaconate. However, fermentation of glucose gives low conversion yields and low productivity. Here, we report the whole-cell bioconversion of citrate to itaconate with enhanced aconitase and cis-aconitate decarboxylase activities by controlling the expression of multiple cadA genes. In addition, this bioconversion system does not require the use of buffers, which reduces the production cost and the byproducts released during purification. Using this whole-cell bioconversion system, we were able to catalyze the conversion of 319.8 mM of itaconate (41.6 g/L) from 500 mM citrate without any buffer system or additional cofactors, with 64.0% conversion in 19 h and a productivity of 2.19 g/L/h. Our bioconversion system suggests very high productivity for itaconate production.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28051098 PMCID: PMC5209708 DOI: 10.1038/srep39768
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Development of itaconate production.
| Strain | Initial substrate concentration | Titer | Productivity | Reference |
|---|---|---|---|---|
| Sucrose or Glucose 250 g/L | N/D | N/D | ||
| Molasses 98 g/L | 27 g/L | 0.08 g/L/h | ||
| Glucose 100 g/L | 35 g/L | 0.28 g/L/h | ||
| Glucose 120 g/L | 53 g/l | N/D | ||
| Glucose or glycerol 80 g/L | 16.7 g/L | 0.11 g/L/h | ||
| Glucose 180 g/L | 129 g/L | 1.15 g/L/h | ||
| Glucose 100 g/L | 26.2 g/L | 0.35 g/L/h | ||
| Glucose 9.01 g/L | 0.69 g/L | 0.01 g/L/h | ||
| Glycerol 70 g/L | 7.23 g/L | 0.08 g/L/h | ||
| Glucose 27 g/l | 32 g/L | 0.45 g/L/h |
N/D; No data.
Figure 1(a) E. coli whole-cell bioconversion strategy and (b) itaconate synthesis pathway in A. terreus (fermentation). In the E. coli whole-cell bioconversion strategy, two enzymes involved in this pathway, aconitase and cis-aconitate decarboxylase, were overexpressed. Unlike A. terreus, E. coli has no organelles, so the reaction proceeds spontaneously without the need for intracellular transport. In A. terreus fermentation, glucose is metabolized through glycolysis and the TCA cycle. Citric acid generated by the TCA cycle is converted to cis-aconitic acid by aconitase in the cytosol. Cis-aconitic acid is transferred to the mitochondria and converted to itaconic acid by cis-aconitate decarboxylase.
Figure 2Conversion of citrate using a two vector system.
Cells were grown in 5 mL of LB medium and 100 μM of IPTG for 48 h at 25 °C. The reaction was conducted using 100 mM citrate at pH 7 and 35 °C.
Figure 3(a) Selection of induction medium. Enzyme expression was higher in LB. However, cell mass was higher in Terrific broth. Itaconate/DCW/Hour (); DCW (). (b) Determination of the optimal citrate concentration; 500 mM citrate produced the highest amount of itaconate. The reaction was conducted at pH 7 and 35 °C for 24 h. Itaconate concentration (bar); Conversion (⚫).
Figure 4(a) Optimal pH and (b) temperature. A pH range from 5 to 8 and a temperature range from 25 to 40 °C was tested. A pH of 5.5 and a temperature of 35 °C were found to be optimal.
Figure 5Effect of surfactant.
Tween 80 increased conversion by 7.04% compared to the control. The reaction was conducted using 500 mM citrate, at pH 5.5 and 35 °C. Itaconate concentration (bar); Conversion (⚫).
Figure 6Time-dependent monitoring of itaconate production.
Citrate/Isocitrate concentration (⚫); Itaconate concentration (■); Cis-aconitate concentration (♦); Conversion (○); and pH(▽).
Strains, plasmids, and primers.
| Strain, plasmid, and primer | Relevant information | Source or reference |
|---|---|---|
| Bacterial strains | ||
| | ||
| DH5α | F | |
| BL21(DE3) | F | Novagen |
| JY001 | BL21(DE3) carrying pHMS01 & pHMS05 | (This study) |
| JY002 | BL21(DE3) carrying pHMS01 & pHMS06 | (This study) |
| Plasmids | ||
| pACYC-duet1 | Co-expression vector, Cmr. 2 MCS site with T7 promoter, lac operator, RBS. P15A replicon. 10 to 12 copy number. | Novagen |
| pCDF-duet1 | Co-expression vector, Specr. 2 MCS site with T7 promoter, lac operator, RBS. CloDF13 replicon. 20 to 40 copy number. | Novagen |
| pRSF-duet1 | Co-expression vector, Kmr. 2 MCS site with T7 promoter, lac operator, RBS. RSF1030 replicon(NTP1). Over 100 copy number. | Novagen |
| pHMS01 | pCDF- duet1, Specr, | (This study) |
| pHMS02 | pACYC-duet1, Cmr, | (This study) |
| pHMS03 | pRSF-duet1, Kmr, | (This study) |
| pHMS04 | pACYC-duet1, Cmr, 2 | (This study) |
| pHMS05 | pRSF-duet1, Kmr, 2 | (This study) |
| pHMS06 | pRSF-duet1, Kmr, 2 | (This study) |
| Primers | ||
| | CTCTAT | |
| | CTCT | |
| | CTCT | |
| | CTCT | |
| | ATCGTC CATATG ATGACCAAGACGAGCGCAG | |
| | CTCT | |
| | CTCT | |
| | CTCTCT | |